First-of-its-Kind: Keikku 2.0 Digital Stethoscope Gains FDA Clearance

Lapsi Health, a health technology company with operations in Europe and the U.S., has launched Keikku 2.0, the world’s first FDA-cleared digital stethoscope with real-time AI-assisted documentation and diagnostics.

Keikku 2.0 combines auscultation, clinical note generation, and AI-powered analysis in a single device. 

It automatically produces ready-to-use clinical notes compatible with major electronic health record (EHR) systems, reducing the administrative burden on clinicians and allowing more time for patient care.

The device uses multiple sensors and AI algorithms to detect cardiac and lung sounds that may indicate disease, providing clinicians with immediate, data-driven insights. 

High-definition microphones ensure accurate recordings even in noisy environments, while encrypted data transmission maintains patient privacy.

Lightweight, wireless, and portable, Keikku 2.0 can be used during hospital rounds, in clinics, or in field care. 

It pairs with smartphones via Bluetooth, with future updates expected to enable independent operation.

Keikku 2.0 is designed to integrate seamlessly into everyday clinical workflows, supporting more efficient, precise, and personalised care for patients while reducing documentation time for healthcare providers.